- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Jawad Saleh: There Are Many Risk Factors for PONV
There are many risk factors for developing postoperative nausea and vomiting (PONV), but a simplified risk score can help with assessing those risk factors, said Jawad N. Saleh, PharmD, BSPharm, BCCCP, BCPS, clinical manager of pharmacy services, Hospital for Special Surgery.
There are many risk factors for developing postoperative nausea and vomiting (PONV), but a simplified risk score can help with assessing those risk factors, said Jawad N. Saleh, PharmD, BSPharm, BCCCP, BCPS, clinical manager of pharmacy services, Hospital for Special Surgery.
Transcript
What are some of the most common risk factors for postoperative nausea and vomiting? How should these risks be assessed to understand treatment?
The risk factors are vast. If you look into it, there's so many risk factors. But based on the Apfel study, if you look at the Apfel simplified risk score—which I actually encourage and it's also encouraged in the consensus guidelines that were recently published—if you're female, that's a risk factor. If you are a nonsmoker, that's a risk factor. If you have a history of PONV or motion sickness, that's a risk factor. And if you're getting opioids, that's a risk factor.
So those are the 4 Apfel simplified risk factors and, honestly, it puts a large number of people in more of a moderate- or high-risk state of PONV. Keeping that in mind, the average PONV rate is 30%; it’s 80% for high-risk patients. At Hospital for Special Surgery, we've been doing an amazing job—we're well below that number. And hopefully, we continue to reduce that number.
Integrating RECIST and Clinician Approaches Boosts NSCLC Research
May 8th 2024Outcomes among patients with stage IV non–small cell lung cancer as evaluated within clinical trials via Response Evaluation Criteria in Solid Tumors (RECIST) and clinician response criteria in observational studies were compared for their concordance and reliability.
Read More
CMS Medicare Final Rule: Advancing Benefits, Competition, and Consumer Protection
May 7th 2024On this episode of Managed Care Cast, we're talking with Karen Iapoce, senior director of government products and programs at ZeOmega, about the recent CMS final rule on Medicare Part D and Medicare Advantage.
Listen
Tackling Health Inequality: The Power of Education and Experience
April 30th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our final episode of this limited series and our conversation with Janine Jelks-Seale, MSPPM, director of health equity at UPMC Health Plan.
Listen
